Aripiprazole Lauroxil

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 4 USDMF, 10 NDC API, 3 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

9 FDF Dossiers, 5 FDA Orange Book, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 1064MG/3.9ML (272.82MG/ML), SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 441MG/1.6ML (275.63MG/ML), SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 662MG/2.4ML (275.83MG/ML), SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 882MG/3.2ML (275.63MG/ML), SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 675MG/2.4ML (281.25MG/ML)

RELATED EXCIPIENT COMPANIES

2 Nanjing Well Pharmaceutical, 2 Actylis, 1 BASF, 1 Gangwal Chemicals, 1 Microlex e.U, 4 Seppic

EXCIPIENTS BY APPLICATIONS

6 Solubilizers, 5 Parenteral, 4 Surfactant & Foaming Agents, 4 Emulsifying Agents, 4 Topical, 2 Thickeners and Stabilizers, 1 Film Formers & Plasticizers